World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023
- PMID: 38916864
- PMCID: PMC11210631
- DOI: 10.3201/eid3007.240354
World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023
Abstract
To determine antimicrobial susceptibility of Neisseria gonorrhoeae, we analyzed phenotypes and genomes of 72 isolates collected in Cambodia in 2023. Of those, 9/72 (12.5%) were extensively drug resistant, a 3-fold increase from 2022. Genomic analysis confirmed expansion of newly emerging resistant clones and ongoing resistance emergence across new phylogenetic backbones.
Keywords: Antimicrobial resistance; Cambodia; Neisseria gonorrhoeae; World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme; bacteria; sexually transmitted infections; surveillance.
Figures

References
-
- World Health Organization. Enhanced Gonococcal Surveillance Programme general protocol [cited 2022 Jan 20]. https://www.who.int/publications/i/item/9789240021341
-
- Ouk V, Pham CD, Wi T, van Hal SJ, Lahra MM. EGASP Cambodia working group. The Enhanced Gonococcal Surveillance Programme, Cambodia. Lancet Infect Dis. 2023;23:e332–3. - PubMed
-
- Maubaret C, Caméléna F, Mrimèche M, Braille A, Liberge M, Mainardis M, et al. Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023. Euro Surveill. 2023;28:2300456. - PMC - PubMed
-
- van der Veen S. Global transmission of the penA allele 60.001–containing high-level ceftriaxone-resistant gonococcal fc428 clone and antimicrobial therapy of associated cases: a review. Infectious Microbes & Diseases. 2023;5:13–20.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical